Dr. Joseph Robert Luvisi, MD

Dr. Luvisi practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Luvisi's NPI, 1043847940, was assigned on March 23, 2020. Dr. Luvisi holds Massachusetts license 1018661.

Dr. Luvisi's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Luvisi's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Luvisi is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Luvisi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Luvisi practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Luvisi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Luvisi is licensed in Massachusetts.

CMS data shows 62 Medicare services from Dr. Luvisi across 3 procedure codes in 2024, for 72 Medicare patients. Medicare paid $3,653 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Luvisi in 2024. The largest group is 65 to 74, with 33 patients. 68% of them have high cholesterol, and 64% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Luvisi's median patient age at 74, with 58% women.

In 2024, Dr. Luvisi wrote 548 Medicare Part D claims for 151 patients. 73% of them were for generic drugs. CMS names the drug for 504 of them, across 12 drugs with 11 or more claims each, at $15,008 in total drug cost. In 2023, CMS named 390 claims across 7 drugs.

Dr. Luvisi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Luvisi, published from 2022 to 2025. 2022 was the busiest year, with 3. Dr. Luvisi has published most often in Ophthalmol Retina. Dr. Luvisi's most frequent co-authors are Emil Anthony T. Say, MD, Jeffrey P. Blice, MD and Susannah Liberty Brown, MD.

CMS Open Payments shows 31 general payments to Dr. Luvisi from 13 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $1,342.